EMA — authorised 21 August 2020
- Marketing authorisation holder: Vertex Pharmaceuticals (Ireland) Limited
- Status: approved
EMA authorised Trikafta (Copackaged) on 21 August 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 21 August 2020.
Vertex Pharmaceuticals (Ireland) Limited holds the EU marketing authorisation.